Drugs / Budesonide/Formoterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05831566 Background | Jan 2023 → Apr 2025 overdue | asthma | Franciscus Gasthuis | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/Formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831566 ↗ |
| Known as | Budesonide/Formoterol fumarate dihydrate | “Drug: Budesonide/Formoterol fumarate dihydrate” NCT05831566 ↗ |
| Route | Inhaled | “inhalation medication” NCT05831566 ↗ |